Related Experiment Video
Updated: May 29, 2026
06:38
Induction of Ocular Surface Inflammation and Collection of Involved Tissues
Published on: August 4, 2022
Serum interleukin-23 levels in patients with ulcerative colitis
Mojgan Mohammadi1, Mohammad Mahdi Hayatbakhsh, Mohammad Javad Zahedi
1Physiology Research Centre, Kerman University of Medical Sciences, Kerman, Iran. mozhganmohammadi69@yahoo.co.uk
Iranian Journal of Immunology : IJI
|September 21, 2011
Summary
Serum Interleukin 23 (IL-23) levels are elevated in ulcerative colitis patients and correlate with disease severity. This suggests IL-23 is a key factor in ulcerative colitis development and a marker for disease activity.
Area of Science:
- Immunology
- Gastroenterology
- Cytokine Research
Background:
- Ulcerative colitis (UC) patients exhibit heightened inflammation risks.
- Interleukin 23 (IL-23) is implicated in Crohn's disease but its role in UC remains unclear.
Purpose of the Study:
- Compare serum IL-23 levels in UC patients versus healthy controls.
- Investigate the correlation between serum IL-23 levels and UC disease severity based on endoscopic findings.
Main Methods:
- Quantified serum IL-23 in 60 UC patients and 20 controls.
- Assessed disease severity via endoscopy, stratifying patients into 'Mild' and 'Severe' groups.
- Utilized Mann-Whitney U, independent t-tests, and correlation analyses.
Main Results:
- Serum IL-23 levels were significantly higher in UC patients than in controls.
- Patients with severe UC displayed elevated serum IL-23 and ESR compared to mild UC patients.
- No significant differences in studied variables based on sex were observed.
Conclusions:
- IL-23 is integral to ulcerative colitis pathogenesis.
- Serum IL-23 serves as a valuable biomarker for assessing UC disease activity.
Related Concept Videos
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...